TECHNOLOGY

CaVESWave® may substantially reduce long waiting lists for organ transplants!

CaVESWave® may substantially reduce long waiting lists for organ transplants! As the transplant community adopts the CaVESWave®, the Company may save thousands of lives…

As the transplant community adopts the CaVESWave®, the Company will save thousands of lives...
BioMed Innovations LLC understands every 10 minutes a new patient is added to the organ wait list

In 2018, 35,268 organ transplants were performed in the United States. Over 58,000 people were added to the transplant list in 2018. Every 10 minutes, a new patient is added to the organ waiting list. By this time tomorrow, 144 anxious and hopeful contenders will add their names to “the list” while 15 list veterans will be removed for burial, and 16 will be removed being too sick for a transplant.

BMI challenges the common belief that there are not enough transplantable organs to meet the demand. The Company redefines the problem as a “shortage of confirmed viable organs available for transplant”—not simply a shortage of organ donors. Understanding this distinction inspired BMI to develop CaVESWave®, which we believe is the most significant technological advances in the field of tissue perfusion in the past 40 years!

The ice box pictured below, first used in the 1970s, remains the most widely used and accepted technology for organ transportation today, whether carried by drone, plane, car or van. Conventional “ice box” technology and other systems used today are designed to merely slow deterioration of explanted organs.

First drone delivery of a kidney in an ice cooler, 20th century cooling, by 21st century delivery!
First drone delivery of a kidney in an ice cooler

The CaVESWave® perfusion system by BMI brings revolutionary technology for organ preservation and global organ health assessment. Pre-clinical testing demonstrates that CaVESWave® preserves organs longer than does current technology, and that it provides real-time organ metrics that transplant
professionals may rely on to make critical decisions regarding organ use! Organ transplant experts
familiar with the CaVESWave® system consider it potentially to be a new paradigm, and BMI intends that it be the new transplantation gold standard of care.

CaVESWave® is an investigative device in the preclinical stage of development. It has not yet been tested extensively on humans or approved for commercial sale by the FDA or by any other regulatory body. ©BMI Proprietary and Confidential